FDA Compliance for Peptide Therapy and BPC 157 Holt Law Last week @fda sends out clarification on who can and cannot compound #glp1 like #tirzeaptide and #semaglutide and this week ProRx 503b shuts down GLP 1 compounding while @martymakary is photographed holding bootleg # 503A Vs. 503B Compounding Pharmacies: Similarities & Differences FDA to Consider Lifting Restrictions on Numerous Compounded Peptides Foley & Lardner What is a 503B outsourcing facility, and why are so many of them uninspected by FDA? Partnership for Safe Medicines